G D Wilner

2.8k total citations · 1 hit paper
36 papers, 2.3k citations indexed

About

G D Wilner is a scholar working on Hematology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, G D Wilner has authored 36 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 10 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in G D Wilner's work include Blood Coagulation and Thrombosis Mechanisms (11 papers), Immunotherapy and Immune Responses (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). G D Wilner is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (11 papers), Immunotherapy and Immune Responses (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). G D Wilner collaborates with scholars based in United States, Switzerland and Canada. G D Wilner's co-authors include H. L. Nossel, Rachel Bar‐Shavit, John W. Fenton, Eric Leroy, A. J. Kahn, V P Butler, R E Canfield, G. D. Qureshi, I. Yudelman and W F Skogen and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

G D Wilner

36 papers receiving 2.1k citations

Hit Papers

Measurement of Fibrinopeptide A in Human Blood 1974 2026 1991 2008 1974 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G D Wilner United States 21 1.1k 633 363 346 325 36 2.3k
VJ Marder United States 26 953 0.9× 678 1.1× 181 0.5× 234 0.7× 178 0.5× 60 1.9k
J. Soria France 27 808 0.7× 850 1.3× 622 1.7× 314 0.9× 129 0.4× 78 2.4k
B Kudryk United States 33 1.1k 1.0× 1.4k 2.3× 586 1.6× 229 0.7× 193 0.6× 69 2.9k
Michio Matsuda Japan 32 1.3k 1.2× 1.2k 1.9× 742 2.0× 198 0.6× 215 0.7× 146 3.0k
Geoffrey F. Savidge United Kingdom 31 1.6k 1.5× 312 0.5× 464 1.3× 301 0.9× 503 1.5× 97 2.8k
Raymond R. Schleef United States 29 1.3k 1.2× 606 1.0× 620 1.7× 316 0.9× 312 1.0× 57 2.7k
Theo Lindhout Netherlands 29 1.7k 1.6× 518 0.8× 471 1.3× 540 1.6× 339 1.0× 68 2.8k
Rima Dardik Israel 29 1.3k 1.1× 515 0.8× 449 1.2× 367 1.1× 281 0.9× 95 2.4k
F De Cock Belgium 27 1.1k 1.0× 719 1.1× 567 1.6× 371 1.1× 122 0.4× 55 2.3k
J.J. Emeis Netherlands 21 1.1k 1.0× 386 0.6× 549 1.5× 218 0.6× 151 0.5× 51 2.4k

Countries citing papers authored by G D Wilner

Since Specialization
Citations

This map shows the geographic impact of G D Wilner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G D Wilner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G D Wilner more than expected).

Fields of papers citing papers by G D Wilner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G D Wilner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G D Wilner. The network helps show where G D Wilner may publish in the future.

Co-authorship network of co-authors of G D Wilner

This figure shows the co-authorship network connecting the top 25 collaborators of G D Wilner. A scholar is included among the top collaborators of G D Wilner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G D Wilner. G D Wilner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dunn, Henry G., et al.. (1997). Hypereosinophilic syndrome and myocardial infarction in a 15-year-old.. PubMed. 17(3). 469–86. 14 indexed citations
2.
Bar‐Shavit, Rachel, Miriam Benezra, Amiram Eldor, et al.. (1990). Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: nonenzymatic mode of action.. PubMed. 1(6). 453–463. 149 indexed citations
3.
Stockmann, Paul T., D. H. Will, Steven R. Brunnert, et al.. (1988). Reversible induction of right ventricular atriopeptin synthesis in hypertrophy due to hypoxia.. Circulation Research. 63(1). 207–213. 40 indexed citations
4.
Perry, H. Mitchell, W F Skogen, Jean Chappel, et al.. (1987). Conditioned medium from osteoblast-like cells mediate parathyroid hormone induced bone resorption. Calcified Tissue International. 40(5). 298–300. 23 indexed citations
5.
Senior, Robert M., W F Skogen, Gail L. Griffin, & G D Wilner. (1986). Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B.. Journal of Clinical Investigation. 77(3). 1014–1019. 186 indexed citations
6.
Thomas, David W., et al.. (1985). Nonrandom catabolism of proteins in the formation of antigenic peptide fragments.. The Journal of Immunology. 135(2). 1259–1263. 7 indexed citations
7.
Picciano, Paul, et al.. (1984). Fibrin-mediated vascular injury. Identification of fibrin peptides that mediate endothelial cell retraction.. PubMed. 117(3). 418–28. 84 indexed citations
8.
Bar‐Shavit, Rachel, A. J. Kahn, John W. Fenton, & G D Wilner. (1983). Receptor-mediated chemotactic response of a macrophage cell line (J774) to thrombin.. PubMed. 49(6). 702–7. 40 indexed citations
9.
Peterson, Laurence B., G D Wilner, & Doris Thomas. (1983). Functional differentiation in the genetic control of murine T lymphocyte responses to human fibrinopeptide B.. The Journal of Immunology. 130(2). 637–643. 9 indexed citations
10.
Thomas, David W., M Hoffman, & G D Wilner. (1982). T lymphocyte recognition of peptide antigens: evidence favoring the formation of neoantigenic determinants.. The Journal of Experimental Medicine. 156(1). 289–293. 5 indexed citations
11.
Wilner, G D, et al.. (1981). Fine specificity of genetic regulation of guinea pig T lymphocyte responses to angiotensin II and related peptides. The Journal of Experimental Medicine. 153(3). 583–594. 34 indexed citations
12.
Thomas, David W., et al.. (1980). Nature of T lymphocyte recognition of macrophage-associated antigens. V. Contribution of individual peptide residues of human fibrinopeptide B to T lymphocyte responses.. The Journal of Experimental Medicine. 152(3). 620–632. 22 indexed citations
13.
Wilner, G D, William J. Casarella, Carla Fenoglio, & Baier Re. (1977). In Vivo Fibrinopeptide a Generation Induced by Angiographic Catheters. Thrombosis and Haemostasis. 1 indexed citations
14.
Nossel, H. L., I. Yudelman, R E Canfield, et al.. (1974). Measurement of Fibrinopeptide A in Human Blood. Journal of Clinical Investigation. 54(1). 43–53. 468 indexed citations breakdown →
15.
Scheidt, S, G D Wilner, S Fillmore, Mia Shapiro, & Thomas Killip. (1973). Objective haemodynamic assessment after acute myocardial infarction.. Heart. 35(9). 908–916. 23 indexed citations
16.
Scheidt, S, G D Wilner, S Fillmore, Charles Smithen, & T Killip. (1972). Dynamic alterations during the impending coronary syndrome. Clinical research. 20(3). 620. 1 indexed citations
17.
Nossel, H. L., G D Wilner, & M Drillings. (1971). Inhibition of collagen-induced platelet aggregation by normal plasma. Journal of Clinical Investigation. 50(10). 2168–2175. 19 indexed citations
18.
Wilner, G D, et al.. (1971). Aggregation of platelets by collagen: polar active sites of insoluble human collagen. American Journal of Physiology-Legacy Content. 220(4). 1074–1079. 36 indexed citations
19.
Wilner, G D, H. L. Nossel, & Eric Leroy. (1968). Activation of hageman factor by collagen. Journal of Clinical Investigation. 47(12). 2608–2615. 164 indexed citations
20.
Wilner, G D, H. L. Nossel, & Eric Leroy. (1968). Aggregation of platelets by collagen. Journal of Clinical Investigation. 47(12). 2616–2621. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026